These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11274587)

  • 1. Risk factors for infection with HBV and HCV in a largecohort of hemophiliac males.
    Soucie JM; Richardson LC; Evatt BL; Linden JV; Ewenstein BM; Stein SF; Leissinger C; Manco-Johnson M; Sexauer CL;
    Transfusion; 2001 Mar; 41(3):338-43. PubMed ID: 11274587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
    Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID
    Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV, HBV and HCV seropositivity in hemophiliacs.
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran.
    Sharifi-Mood B; Eshghi P; Sanei-Moghaddam E; Hashemi M
    Saudi Med J; 2007 Oct; 28(10):1516-9. PubMed ID: 17914511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
    Mannucci PM; Schimpf K; Brettler DB; Ciavarella N; Colombo M; Haschke F; Lechner K; Lusher J; Weissbach G
    Ann Intern Med; 1990 Jul; 113(1):27-32. PubMed ID: 2112352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs.
    Schramm W; Roggendorf M; Rommel F; Kammerer R; Pohlmann H; Rasshofer R; Gürtler L; Deinhardt F
    Blut; 1989 Oct; 59(4):390-2. PubMed ID: 2506955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage liver disease in persons with hemophilia and transfusion-associated infections.
    Goedert JJ; Eyster ME; Lederman MM; Mandalaki T; De Moerloose P; White GC; Angiolillo AL; Luban NL; Sherman KE; Manco-Johnson M; Preiss L; Leissinger C; Kessler CM; Cohen AR; DiMichele D; Hilgartner MW; Aledort LM; Kroner BL; Rosenberg PS; Hatzakis A
    Blood; 2002 Sep; 100(5):1584-9. PubMed ID: 12176875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
    Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
    Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
    Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
    Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy.
    Popovici O; Molnar GB; Popovici F; Janţă D; Pistol A; Azoicăi D
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):25-32. PubMed ID: 27014751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan.
    Borhany M; Shamsi T; Boota S; Ali H; Tahir N; Naz A; Naseer I; Farzana T; Ansari S; Nadeem M; Zia-Ur-Rahman ; Sangji Z
    Clin Appl Thromb Hemost; 2011; 17(6):651-5. PubMed ID: 21406412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.
    Janjua NZ; Yu A; Kuo M; Alvarez M; Cook D; Wong J; Tyndall MW; Krajden M
    BMC Infect Dis; 2016 Jul; 16():334. PubMed ID: 27436414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients.
    Covas DT; Boturão Neto E; Zago MA
    Rev Inst Med Trop Sao Paulo; 1993; 35(3):271-3. PubMed ID: 8278757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs].
    Windyga J; Grabarczyk P; Stefańska E; Buczma A; Szczepanik AB; Klukowska A; Mikulska M; Medyńska J; Brojer E
    Przegl Epidemiol; 2008; 62(2):415-23. PubMed ID: 18807489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
    Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
    Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBV, HCV and HIV infections among drug addicts-residents of rehabilitation and social adjustment centers in the Gdańsk district].
    Smiatacz T; Własiuk M; Paszkiewicz J; Zielińska W
    Przegl Epidemiol; 1991; 45(4):351-5. PubMed ID: 1841415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care.
    Pappoe F; Hagan CKO; Obiri-Yeboah D; Nsiah P
    BMC Infect Dis; 2019 May; 19(1):380. PubMed ID: 31053100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.